| Studies ever conducted, n | |
| 1–3 | 29 (24.0) |
| 4–7 | 24 (19.8) |
| 8–16 | 25 (20.7) |
| 17–39 | 21 (17.4) |
| ≥40 | 22 (18.2) |
| Used EHR for research | 83 (68.6) |
| AHRQ priority health conditions studied (during past 5 years)* | |
| Diabetes mellitus | 60 (49.6) |
| Obesity | 51 (42.1) |
| Pulmonary disease/asthma | 44 (36.4) |
| Cardiovascular disease | 42 (34.7) |
| Mental health disorders | 34 (28.1) |
| Cancer | 32 (26.4) |
| Substance abuse | 18 (14.9) |
| Development delays | 14 (11.6) |
| Infectious disease (including HIV/AIDs, sexually transmitted diseases) | 13 (10.7) |
| Dementia | 11 (9.1) |
| Arthritis and joint disease | 10 (8.3) |
| Pregnancy and childbirth | 10 (8.3) |
| Study designs used (during past 5 years)* | |
| Observational epidemiology | 66 (54.5) |
| Health systems/outcome research | 63 (52.1) |
| Best practice research/modeling | 61 (50.4) |
| Implementation research | 39 (32.2) |
| Clinical trials | 34 (28.1) |
| Comparative effectiveness research | 31 (25.6) |
| Methodological research | 22 (18.2) |
| Nonpractice-based community health intervention | 18 (14.9) |
| Pharmaceutical clinical trials | 12 (9.9) |
Data provided as n (%). Ten developing PBRNs that had not completed a research project were excluded from the description of PBRN research.
↵* Multiple responses permitted.
EHR, electronic health record; AHRQ, Agency for Health care Research and Quality.